Answers are grounded in this paper and cite their sources.
These guidelines are based on many years experience in the use of platelet transfusions by the authors, on searching the literature in MedLine and other databases using appropriate keywords, and a review of the existing guidelines published by expert groups [British Committee for Standards in Haematology (BCSH), 1992; Schiffer et al, 2001], including a previous guideline on platelet transfusions (BCSH, 1992) and the recommendations of Consensus Conferences (National Institutes of Health Consensus Conference, 1987; Consensus Conference on Platelet Transfusion, 1998).The section on indications for platelet transfusions was drafted in collaboration with the Haemato-Oncology Task Force of the BCSH.The authors were selected to encompass a wide range of interests in platelet transfusion therapy, including clinical and laboratory haematology, paediatrics, surgery, anaesthetics and critical care, and nursing. GRADING OF EVIDENCE AND STRENGTH OF RECOMMENDATIONSThe definitions of the types of evidence and the grading of recommendations used in this guideline originate from the US Agency for Health Care Policy and Research and are set out in Appendix I.
No takes yet. Share an insight, caveat, or question.
A 2003 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: